doripenem (Doribax)

Advice

On 31 July 2014, the European Commission issued a decision to withdraw the marketing authorisation for Doribax, following its receipt of a letter dated 6 July 2014 notifying the Commission of the MAH’s decision to voluntarily withdraw the marketing authorisation for this product for commercial reasons. Please see link to European Medicines Agency statement.

Medicine details

Medicine name:: doripenem (Doribax)
SMC ID:: 539/09
Indication:: Nosocomial pneumonia including ventilator acquired pneumonia
Pharmaceutical company: Janssen-Cilag Ltd
BNF chapter: Infections
Submission type: Full
Status: Withdrawn
Date advice published: 08 March 2009

Additional notes

On 31 July 2014 the European Commission issued a decision to withdraw the marketing authorisation for Doribax following its receipt of a letter dated 6 July 2014 notifying the Commission of the MAH’s decision to voluntarily withdraw the marketing authorisation for this product for commercial reasons.